Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Louis Matis > Profile

Louis Matis

Affiliations

Chief Development Officer at Pieris Pharmaceuticals Inc. (PIRS), 2019-02-28

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
PIRS	$1.71	7,915	$13,534.65	10,000	2016-06-14	Filing
PIRS	$1.68	2,085	$3,502.80	2,085	2016-06-13	Filing